These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 37119861)
21. A small step toward precision dosing of caffeine in preterm infants: An external evaluation of published population pharmacokinetic models. Dai HR; Liu Y; Guo HL; Lu KY; Hu YH; Zhang YY; Wang J; Ding XS; Jiao Z; Cheng R; Chen F Eur J Pharm Biopharm; 2024 Nov; 204():114484. PubMed ID: 39251033 [TBL] [Abstract][Full Text] [Related]
22. External evaluation of published population pharmacokinetic models of posaconazole. Huang S; Ding Q; Yang N; Sun Z; Cheng Q; Liu W; Li Y; Chen X; Wu C; Pei Q Front Pharmacol; 2022; 13():1005348. PubMed ID: 36249756 [TBL] [Abstract][Full Text] [Related]
23. Evaluating tacrolimus pharmacokinetic models in adult renal transplant recipients with different CYP3A5 genotypes. Hu C; Yin WJ; Li DY; Ding JJ; Zhou LY; Wang JL; Ma RR; Liu K; Zhou G; Zuo XC Eur J Clin Pharmacol; 2018 Nov; 74(11):1437-1447. PubMed ID: 30019212 [TBL] [Abstract][Full Text] [Related]
24. Published population pharmacokinetic models of valproic acid in adult patients: a systematic review and external validation in a Chinese sample of inpatients with bipolar disorder. Zang YN; Guo W; Dong F; Li AN; de Leon J; Ruan CJ Expert Rev Clin Pharmacol; 2022 May; 15(5):621-635. PubMed ID: 35536685 [TBL] [Abstract][Full Text] [Related]
25. Towards Precision Dosing of Clozapine in Schizophrenia: External Evaluation of Population Pharmacokinetic Models and Bayesian Forecasting. Lereclus A; Korchia T; Riff C; Dayan F; Blin O; Benito S; Guilhaumou R Ther Drug Monit; 2022 Oct; 44(5):674-682. PubMed ID: 35385439 [TBL] [Abstract][Full Text] [Related]
26. Predictive Performance of Population Pharmacokinetic Models of Levetiracetam in Children and Evaluation of Dosing Regimen. Tauzin M; Tréluyer JM; Nabbout R; Chemaly N; Billette de Villemeur T; Desguerre I; Lui G; Gana I; Boujaafar S; Zheng Y; Benaboud S; Bouazza N; Chenevier-Gobeaux C; Freihuber C; Hirt D J Clin Pharmacol; 2021 Oct; 61(10):1366-1375. PubMed ID: 33997989 [TBL] [Abstract][Full Text] [Related]
27. External evaluation of population pharmacokinetic models of imatinib in adults diagnosed with chronic myeloid leukaemia. Corral Alaejos Á; Zarzuelo Castañeda A; Jiménez Cabrera S; Sánchez-Guijo F; Otero MJ; Pérez-Blanco JS Br J Clin Pharmacol; 2022 Feb; 88(4):1913-1924. PubMed ID: 34705297 [TBL] [Abstract][Full Text] [Related]
28. High-dose methotrexate in adults with osteosarcoma: a population pharmacokinetics study and validation of a new limited sampling strategy. Dupuis C; Mercier C; Yang C; Monjanel-Mouterde S; Ciccolini J; Fanciullino R; Pourroy B; Deville JL; Duffaud F; Bagarry-Liegey D; Durand A; Iliadis A; Favre R Anticancer Drugs; 2008 Mar; 19(3):267-73. PubMed ID: 18510172 [TBL] [Abstract][Full Text] [Related]
29. Population pharmacokinetics of high-dose methotrexate in children with acute lymphoblastic leukaemia. Aumente D; Buelga DS; Lukas JC; Gomez P; Torres A; García MJ Clin Pharmacokinet; 2006; 45(12):1227-38. PubMed ID: 17112298 [TBL] [Abstract][Full Text] [Related]
30. Simulations of Valproate Doses Based on an External Evaluation of Pediatric Population Pharmacokinetic Models. Tauzin M; Tréluyer JM; Nabbout R; Billette de Villemeur T; Desguerre I; Aboura R; Gana I; Zheng Y; Benaboud S; Bouazza N; Chenevier-Gobeaux C; Freihuber C; Hirt D J Clin Pharmacol; 2019 Mar; 59(3):406-417. PubMed ID: 30412268 [TBL] [Abstract][Full Text] [Related]
31. Can Published Population Pharmacokinetic Models of Busulfan Be Used for Individualized Dosing in Chinese Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation? An External Evaluation. Huang H; Liu M; Ren J; Hu J; Lin S; Li D; Huang W; Chen S; Yang T; Wu X J Clin Pharmacol; 2022 May; 62(5):609-619. PubMed ID: 34695225 [TBL] [Abstract][Full Text] [Related]
32. External Evaluation of Population Pharmacokinetic Models of Vancomycin in Neonates: The transferability of published models to different clinical settings. Zhao W; Kaguelidou F; Biran V; Zhang D; Allegaert K; Capparelli EV; Holford N; Kimura T; Lo YL; Peris JE; Thomson A; van den Anker JN; Fakhoury M; Jacqz-Aigrain E Br J Clin Pharmacol; 2013 Apr; 75(4):1068-80. PubMed ID: 23148919 [TBL] [Abstract][Full Text] [Related]
33. Towards Model-Informed Precision Dosing of Voriconazole: Challenging Published Voriconazole Nonlinear Mixed-Effects Models with Real-World Clinical Data. Kluwe F; Michelet R; Huisinga W; Zeitlinger M; Mikus G; Kloft C Clin Pharmacokinet; 2023 Oct; 62(10):1461-1477. PubMed ID: 37603216 [TBL] [Abstract][Full Text] [Related]
34. External validation of vancomycin population pharmacokinetic models in ten cohorts of infected Chinese patients. Zhou Y; Long E; Shi T; Wang Z; Zhao J; Liu H; Lin Y; Jiang M; Lao H; Ge W; Cui Y J Glob Antimicrob Resist; 2022 Sep; 30():163-172. PubMed ID: 35640870 [TBL] [Abstract][Full Text] [Related]
35. Predictive performance of reported population pharmacokinetic models of vancomycin in Chinese adult patients. Deng C; Liu T; Wu K; Wang S; Li L; Lu H; Zhou T; Cheng D; Zhong X; Lu W J Clin Pharm Ther; 2013 Dec; 38(6):480-9. PubMed ID: 24033587 [TBL] [Abstract][Full Text] [Related]
36. Bayesian estimation and prediction of clearance in high-dose methotrexate infusions. Iliadis A; Bachir-Raho M; Bruno R; Favre R J Pharmacokinet Biopharm; 1985 Feb; 13(1):101-15. PubMed ID: 3839529 [TBL] [Abstract][Full Text] [Related]
37. A Systematic Review of Population Pharmacokinetic Models of Methotrexate. Zhang Y; Sun L; Chen X; Zhao L; Wang X; Zhao Z; Mei S Eur J Drug Metab Pharmacokinet; 2022 Mar; 47(2):143-164. PubMed ID: 34985725 [TBL] [Abstract][Full Text] [Related]
38. Population Pharmacokinetic Modeling Combined With Machine Learning Approach Improved Tacrolimus Trough Concentration Prediction in Chinese Adult Liver Transplant Recipients. Li ZR; Li RD; Niu WJ; Zheng XY; Wang ZX; Zhong MK; Qiu XY J Clin Pharmacol; 2023 Mar; 63(3):314-325. PubMed ID: 36097320 [TBL] [Abstract][Full Text] [Related]
39. High dose methotrexate population pharmacokinetics and Bayesian estimation in patients with lymphoid malignancy. Min Y; Qiang F; Peng L; Zhu Z Biopharm Drug Dispos; 2009 Nov; 30(8):437-47. PubMed ID: 19746402 [TBL] [Abstract][Full Text] [Related]
40. External Evaluation of Population Pharmacokinetic Models to Inform Precision Dosing of Meropenem in Critically Ill Patients. Yang N; Wang J; Xie Y; Ding J; Wu C; Liu J; Pei Q Front Pharmacol; 2022; 13():838205. PubMed ID: 35662716 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]